Development of robust self-emulsifying drug delivery system (SEDDS) formulations must be grounded in in-depth analysis and understanding of the drug’s physicochemical and biological characteristics. Based on these characteristics, selection of lipid-based excipients with specific physiological effects may be required. This poster describes work to leverage know-how and methodologies to develop lipid formulations that address solubility and metabolic barriers to the oral bioavailability of a low-solubility compound.
Please note that Lonza has updated its Privacy Policy. By visiting our website or using services provided by Lonza, you are accepting the practices described in the Privacy Policy.
We also use cookies on our websites. Cookies allow us to give you the best browsing experience and help us to understand how you use our site. You can disable cookies but parts of our website may not work. Please read our updated Cookies Policy for information about which cookies we use and the information we collect. By continuing to use this website, you agree that we may store and access cookies on your device.
By clicking "I Agree", you confirm that you are above the age of 16, that you have read and understood the Privacy Policy and the Cookies Policy, and that you agree to the collection, use and processing of your Personal Information by Lonza in accordance with said policies.